...
首页> 外文期刊>Molecular and Cellular Biology >NF-κB-Dependent Assembly of an Enhanceosome-Like Complex on the Promoter Region of Apoptosis Inhibitor Bfl-1/A1
【24h】

NF-κB-Dependent Assembly of an Enhanceosome-Like Complex on the Promoter Region of Apoptosis Inhibitor Bfl-1/A1

机译:NF-κB依赖的凋亡抑制剂Bfl-1 / A1启动子区域上类似增强体的组装。

获取原文
           

摘要

Expression of the prosurvival Bcl-2 homologue Bfl-1/A1 is induced by NF-κB-activating stimuli, while B and T cells from c-rel knockout mice show an absolute defect in bfl-1/a1 gene activation. Here, we demonstrate NF-κB-dependent assembly of an enhanceosome-like complex on the promoter region of bfl-1. Binding of NF-κB subunit c-Rel to DNA nucleated the concerted binding of transcription factors AP-1 and C/EBPβ to the 5′-regulatory region of bfl-1. Optimal stability of the complex was dependent on proper orientation and phasing of the NF-κB site. Chromatin immunoprecipitation analyses demonstrated that T-cell activation triggers in vivo binding of endogenous c-Rel, c-Jun, C/EBPβ, and HMG-IC to the bfl-1 regulatory region, coincident with selective recruitment of coactivators TAFII250 and p300, SWI/SNF chromatin remodeling factor component BRG-1, and basal transcription factors TATA-binding protein (TBP) and TFIIB, as well as hyperacetylation of histones H3 and H4. These results highlight a critical role for NF-κB in bfl-1 transcription and point to the need for a complex and precise regulatory network to control bfl-1 expression. To our knowledge, this is the first demonstration of enhanceosome-mediated regulation of a cell death inhibitor.
机译:NF-κB激活刺激诱导生存前Bcl-2同源物Bfl-1 / A1的表达,而c- rel 基因敲除小鼠的B细胞和T细胞在 bfl中显示出绝对缺陷-1 / a1 基因激活。在这里,我们证明了 bfl-1 启动子区域上增强子体样复合物的NF-κB依赖性组装。 NF-κB亚基c-Rel与DNA的结合使转录因子AP-1和C /EBPβ与 bfl-1 的5'调控区域协调一致地结合。配合物的最佳稳定性取决于NF-κB位点的正确方向和相位。染色质免疫沉淀分析表明,T细胞活化触发体内内源性c-Rel,c-Jun,C /EBPβ和HMG-IC与 bfl-1 调节区域的结合,这与选择性募集相符共激活剂TAFII250和p300,SWI / SNF染色质重塑因子组分BRG-1,基础转录因子TATA结合蛋白(TBP)和TFIIB以及组蛋白H3和H4的超乙酰化。这些结果突显了NF-κB在 bfl-1 转录中的关键作用,并指出需要一个复杂而精确的调控网络来控制 bfl-1 的表达。据我们所知,这是增强体介导的细胞死亡抑制剂调控的首次证明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号